ASCI / Emerging-Generation Awards, 2022

Mark B. Leick, MD, grew up in Tucson, Arizona, attending the University of Arizona where he completed majors in biosystems engineering, biochemistry and molecular biophysics, and molecular and cellular biology, graduating magna cum laude with admission to Phi Beta Kappa and Tau Beta Pi. He then attended Georgetown School of Medicine in Washington DC where he was elected into Alpha Omega Alpha. He underwent training in internal medicine in the Johns Hopkins Osler program in Baltimore, Maryland and then completed his medical training with a clinical fellowship in medical oncology in the Harvard combined fellowship with Dana-Farber Cancer Institute and Massachusetts General Hospital with a clinical focus on bone marrow transplantation and cellular therapy. Dr. Leick joined the Maus lab in 2018 where he focuses on developing novel CAR-T cells for AML and translational investigations into patient samples including use of whole genome sequencing and single-cell RNA sequencing. He currently splits his time between the lab and caring for CAR-T and BMT patients at Massachusetts General Hospital.